Age-Specific Incidence of A/H1N1 2009 Influenza Infection in England from Sequential Antibody Prevalence Data Using Likelihood-Based Estimation
Open Access
- 23 February 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (2) , e17074
- https://doi.org/10.1371/journal.pone.0017074
Abstract
Estimating the age-specific incidence of an emerging pathogen is essential for understanding its severity and transmission dynamics. This paper describes a statistical method that uses likelihoods to estimate incidence from sequential serological data. The method requires information on seroconversion intervals and allows integration of information on the temporal distribution of cases from clinical surveillance. Among a family of candidate incidences, a likelihood function is derived by reconstructing the change in seroprevalence from seroconversion following infection and comparing it with the observed sequence of positivity among the samples. This method is applied to derive the cumulative and weekly incidence of A/H1N1 pandemic influenza in England during the second wave using sera taken between September 2009 and February 2010 in four age groups (1–4, 5–14, 15–24, 25–44 years). The highest cumulative incidence was in 5–14 year olds (59%, 95% credible interval (CI): 52%, 68%) followed by 1–4 year olds (49%, 95% CI: 38%, 61%), rates 20 and 40 times higher respectively than estimated from clinical surveillance. The method provides a more accurate and continuous measure of incidence than achieved by comparing prevalence in samples grouped by time period.Keywords
This publication has 14 references indexed in Scilit:
- The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong KongClinical Infectious Diseases, 2010
- Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from ModelingPLoS Medicine, 2010
- Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre studyBMJ, 2010
- Real-Time Epidemic Monitoring and Forecasting of H1N1-2009 Using Influenza-Like Illness from General Practice and Family Doctor Clinics in SingaporePLOS ONE, 2010
- Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluationVaccine, 2010
- Comparisons with recent flu mortalityBMJ, 2010
- Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological studyPublished by Elsevier ,2010
- Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted VaccineNew England Journal of Medicine, 2009
- Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance studyBMJ, 2009
- The Severity of Pandemic H1N1 Influenza in the United States, from April to July 2009: A Bayesian AnalysisPLoS Medicine, 2009